Citius Oncology Investigation Underway Amid Fiduciary Duty Concerns.

lunes, 5 de enero de 2026, 10:34 am ET1 min de lectura
CTOR--

Purcell & Lefkowitz LLP is investigating Citius Oncology, Inc. (NASDAQ: CTOR) on behalf of shareholders, seeking to determine if directors breached their fiduciary duties in recent corporate actions. Shareholders can visit the firm's website or contact Robert H. Lefkowitz for more information. Purcell & Lefkowitz LLP represents shareholders nationwide who are victims of securities fraud, breaches of fiduciary duty, and other corporate misconduct.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios